|
Volumn 133, Issue 6, 2008, Pages 1293-1295
|
Reflecting on eight editions of the American College of Chest Physicians antithrombotic guidelines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ARGATROBAN;
CLOPIDOGREL;
DIPYRIDAMOLE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
FONDAPARINUX;
HEPARIN;
HIRUDIN;
HIRULOG;
LOW MOLECULAR WEIGHT HEPARIN;
RETOPLASE;
STREPTOKINASE;
TENECTEPLASE;
TICLOPIDINE;
TISSUE PLASMINOGEN ACTIVATOR;
BLEEDING;
BRAIN ARTERY;
CONCEPTUAL FRAMEWORK;
CORONARY ARTERY;
DRUG INDUSTRY;
DRUG MONITORING;
EDITORIAL;
EVIDENCE BASED MEDICINE;
FIBRINOLYTIC THERAPY;
HEART VALVE PROSTHESIS;
HEPARIN INDUCED THROMBOCYTOPENIA;
HUMAN;
METHODOLOGY;
PEDIATRICS;
PRACTICE GUIDELINE;
PREGNANCY;
PRIORITY JOURNAL;
PUBLICATION;
THROMBOEMBOLISM;
|
EID: 45949106429
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.08-0782 Document Type: Editorial |
Times cited : (20)
|
References (8)
|